KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Inventory Average (2016 - 2025)

Sarepta Therapeutics (SRPT) has 8 years of Inventory Average data on record, last reported at $1.0 billion in Q3 2025.

  • For Q3 2025, Inventory Average changed N/A year-over-year to $1.0 billion; the TTM value through Sep 2025 reached $1.0 billion, changed N/A, while the annual FY2024 figure was $536.4 million, 103.64% up from the prior year.
  • Inventory Average reached $1.0 billion in Q3 2025 per SRPT's latest filing, up from $967.7 million in the prior quarter.
  • Across five years, Inventory Average topped out at $1.0 billion in Q3 2025 and bottomed at $203.3 million in Q1 2023.
  • Average Inventory Average over 3 years is $482.5 million, with a median of $278.6 million recorded in 2021.
  • The widest YoY moves for Inventory Average: up 44.29% in 2021, down 5.0% in 2021.
  • A 3-year view of Inventory Average shows it stood at $237.3 million in 2021, then grew by 19.42% to $283.4 million in 2023, then surged by 265.38% to $1.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $1.0 billion in Q3 2025, $967.7 million in Q2 2025, and $845.7 million in Q1 2025.